According to an April 28 news release from the Justice Department, the settlement resolves allegations that Joel Aronowitz, MD, his son Daniel Aronowitz, and Dr. Aronowitz’s medical practices and billing company submitted false claims to government payers.
The Justice Department alleged Dr. Aronowitz manipulated billing codes for skin graft procedures to maximize reimbursement. The department also alleges Dr. Aronowitz improperly disposed of single-use skin grafts and reused portions for later procedures. The improper disposal resulted in “thousands of instances” of double-billing to Medicare and Medicaid, the department alleges.
As part of the settlement, Dr. Aronowitz and his practice are barred from billing Medicare or Medicaid for 15 years. Daniel Aronowitz is excluded for three years.
The state of California paid a portion of the alleged false Medicaid claims and will receive nearly $500,000 in the settlement.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
